| Autor: |
Maschera, B., Ferrazzi, E., Rassu, M., Toni, M., Palù, G. |
| Zdroj: |
Antiviral Chemistry & Chemotherapy; April 1993, Vol. 4 Issue: 2 p85-91, 7p |
| Abstrakt: |
Anti-eukaryotic topoisomerase drugs, Camptothecin and Etoposide, were tested for their ability of selectively interfering with the replication of simian virus 40 (SV40) DNA. Nalidixic acid was also assayed for a comparison, since the compound has been previously reported to affect papoyavirus growth. Our results indicate that anti-eukaryotic topoisomerase drugs significantly inhibit viral DNA replication but at concentrations that are also toxic for uninfected cells. Etoposide treatment produced a relatively higher number of DNA-protein cross-links in virus-infected cells as compared to uninfected control cells. Nalidixic acid displayed some degree of selectivity for inhibiting SV40 DNA synthesis more effectively than synthesis of cellular DNA without appreciable reduction of cell growth. This activity does not appear to depend on DNA damage or interference with topoisomerase II and deserves further evaluation. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
